Fresenius Medical Care | FME - Cash And Equivalent


Fresenius Medical Care reported EUR1.24B in Cash and Equivalent for its fiscal quarter ending in March of 2026.





Cash And Equivalent Change Date
Akzo Nobel EUR 1.62B 66M Dec/2025
Alcon AG USD 1.58B 80M Mar/2026
AstraZeneca USD 7.56B 1.85B Mar/2026
Bayer EUR 6.67B 774M Dec/2025
Beiersdorf EUR 1.2B 33M Dec/2025
DaVita Healthcare Partners USD 644.24M 32.2M Mar/2026
Demant DKK 1.33B 188M Dec/2025
E.ON EUR 4.87B 1.83B Mar/2026
Essilor EUR 3.54B 758M Dec/2025
Fresenius EUR 1.31B 81M Dec/2025
Fresenius Medical Care EUR 1.24B 343.37M Mar/2026
Genmab DKK 1.72B 46M Dec/2025
Getinge SEK 2.05B 909M Jun/2026
Givaudan CHF 603M 3M Jun/2024
GlaxoSmithKline GBP 3.44B 292M Mar/2026
GN Store Nord DKK 1.12B 352M Dec/2025
GRIFOLS EUR 801M 242.31M Dec/2025
Hikma Pharmaceutical USD 236M 48M Jun/2025
Lonza CHF 719M 188M Dec/2025
Merck EUR 2.33B 77M Dec/2025
Novartis USD 6.88B 4.56B Mar/2026
Philips EUR 2.79B 882M Dec/2025
Roche Holding CHF 7.55B 579M Jun/2025
RWE EUR 7.73B 4.68B Dec/2025
Sanofi EUR 7.66B 1.25B Dec/2025
SAP EUR 10.04B 1.83B Mar/2026